Myrthe W. van den Dungen, Mélina Galano, Peter J.I. van de Vondervoort, Irsan Kooi, Angela de Bruine, Noël N.M.E. van Peij, Hanna E. Abbas-Lindfors
{"title":"一株镰刀菌生产的含磷脂酶活性食品酶的安全性评价","authors":"Myrthe W. van den Dungen, Mélina Galano, Peter J.I. van de Vondervoort, Irsan Kooi, Angela de Bruine, Noël N.M.E. van Peij, Hanna E. Abbas-Lindfors","doi":"10.1016/j.fct.2025.115484","DOIUrl":null,"url":null,"abstract":"<div><div>Phospholipases are commonly used food enzymes, e.g. to improve bread-making properties. For organic food certifications, enzymes need to be produced by non-genetically modified organisms, but no such ‘classical’ phospholipases are currently available. To this aim, a phospholipase product was developed with a <em>Fusarium commune</em> strain, a microorganism having no reported uses in the food industry. The safety of microbially-derived food enzymes depends largely on the safety of the production strain. Strain <em>F. commune</em> LFC was obtained by classical strain improvement. Whole-Genome Sequencing and literature search allowed to identify potential gene clusters for the mycotoxins beauvericin (BEA), moniliformin (MON), and fusaric acid (FA). Analysis of these mycotoxins revealed that no toxicologically relevant levels were produced during controlled submerged fermentation. The enzyme concentrate was assessed in a range of toxicity studies. The Ames test (OECD 471) was concluded to be equivocal, but the ToxTracker® AO assay suggested an indirect mode of action, induced by dose-dependent oxidative stress. The in vitro micronucleus test (OECD 487) and the in vivo follow-up Comet assay (OECD 489) confirmed that the food enzyme was not genotoxic. The repeated-dose oral toxicity study (OECD 408) showed no adverse effects in any of the treatment groups and allowed to derive a NOAEL of 1124 mg TOS/kg bw/day. The Margin of Exposure with estimated dietary intakes in human food applications was determined to be > 2500. It is therefore concluded that the use of the phospholipase enzyme LFC as processing aid in baking and other cereal-based applications is safe.</div></div>","PeriodicalId":317,"journal":{"name":"Food and Chemical Toxicology","volume":"201 ","pages":"Article 115484"},"PeriodicalIF":3.9000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety evaluation of a food enzyme containing phospholipase activity produced by a strain of Fusarium commune\",\"authors\":\"Myrthe W. van den Dungen, Mélina Galano, Peter J.I. van de Vondervoort, Irsan Kooi, Angela de Bruine, Noël N.M.E. van Peij, Hanna E. Abbas-Lindfors\",\"doi\":\"10.1016/j.fct.2025.115484\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Phospholipases are commonly used food enzymes, e.g. to improve bread-making properties. For organic food certifications, enzymes need to be produced by non-genetically modified organisms, but no such ‘classical’ phospholipases are currently available. To this aim, a phospholipase product was developed with a <em>Fusarium commune</em> strain, a microorganism having no reported uses in the food industry. The safety of microbially-derived food enzymes depends largely on the safety of the production strain. Strain <em>F. commune</em> LFC was obtained by classical strain improvement. Whole-Genome Sequencing and literature search allowed to identify potential gene clusters for the mycotoxins beauvericin (BEA), moniliformin (MON), and fusaric acid (FA). Analysis of these mycotoxins revealed that no toxicologically relevant levels were produced during controlled submerged fermentation. The enzyme concentrate was assessed in a range of toxicity studies. The Ames test (OECD 471) was concluded to be equivocal, but the ToxTracker® AO assay suggested an indirect mode of action, induced by dose-dependent oxidative stress. The in vitro micronucleus test (OECD 487) and the in vivo follow-up Comet assay (OECD 489) confirmed that the food enzyme was not genotoxic. The repeated-dose oral toxicity study (OECD 408) showed no adverse effects in any of the treatment groups and allowed to derive a NOAEL of 1124 mg TOS/kg bw/day. The Margin of Exposure with estimated dietary intakes in human food applications was determined to be > 2500. It is therefore concluded that the use of the phospholipase enzyme LFC as processing aid in baking and other cereal-based applications is safe.</div></div>\",\"PeriodicalId\":317,\"journal\":{\"name\":\"Food and Chemical Toxicology\",\"volume\":\"201 \",\"pages\":\"Article 115484\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Food and Chemical Toxicology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0278691525002522\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Food and Chemical Toxicology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278691525002522","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Safety evaluation of a food enzyme containing phospholipase activity produced by a strain of Fusarium commune
Phospholipases are commonly used food enzymes, e.g. to improve bread-making properties. For organic food certifications, enzymes need to be produced by non-genetically modified organisms, but no such ‘classical’ phospholipases are currently available. To this aim, a phospholipase product was developed with a Fusarium commune strain, a microorganism having no reported uses in the food industry. The safety of microbially-derived food enzymes depends largely on the safety of the production strain. Strain F. commune LFC was obtained by classical strain improvement. Whole-Genome Sequencing and literature search allowed to identify potential gene clusters for the mycotoxins beauvericin (BEA), moniliformin (MON), and fusaric acid (FA). Analysis of these mycotoxins revealed that no toxicologically relevant levels were produced during controlled submerged fermentation. The enzyme concentrate was assessed in a range of toxicity studies. The Ames test (OECD 471) was concluded to be equivocal, but the ToxTracker® AO assay suggested an indirect mode of action, induced by dose-dependent oxidative stress. The in vitro micronucleus test (OECD 487) and the in vivo follow-up Comet assay (OECD 489) confirmed that the food enzyme was not genotoxic. The repeated-dose oral toxicity study (OECD 408) showed no adverse effects in any of the treatment groups and allowed to derive a NOAEL of 1124 mg TOS/kg bw/day. The Margin of Exposure with estimated dietary intakes in human food applications was determined to be > 2500. It is therefore concluded that the use of the phospholipase enzyme LFC as processing aid in baking and other cereal-based applications is safe.
期刊介绍:
Food and Chemical Toxicology (FCT), an internationally renowned journal, that publishes original research articles and reviews on toxic effects, in animals and humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs, and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products, and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques, particularly those fostering the 3 Rs.
The principal aim of the journal is to publish high impact, scholarly work and to serve as a multidisciplinary forum for research in toxicology. Papers submitted will be judged on the basis of scientific originality and contribution to the field, quality and subject matter. Studies should address at least one of the following:
-Adverse physiological/biochemical, or pathological changes induced by specific defined substances
-New techniques for assessing potential toxicity, including molecular biology
-Mechanisms underlying toxic phenomena
-Toxicological examinations of specific chemicals or consumer products, both those showing adverse effects and those demonstrating safety, that meet current standards of scientific acceptability.
Authors must clearly and briefly identify what novel toxic effect (s) or toxic mechanism (s) of the chemical are being reported and what their significance is in the abstract. Furthermore, sufficient doses should be included in order to provide information on NOAEL/LOAEL values.